New Directions in Imaging Neuroendocrine Neoplasms

Area of Science:

• Medical Imaging
• Oncology
• Nuclear Medicine

Background:

• Accurate diagnosis, staging, and therapy of neuroendocrine neoplasms (NENs) are critically dependent on effective imaging modalities.
• The field is rapidly evolving in pursuit of optimal imaging techniques for NENs.

Purpose of the Study:

• To provide a comprehensive overview of current imaging methods for NENs.
• To highlight recent advancements and future directions in NEN imaging.

Main Methods:

• Review of contemporary imaging techniques for NENs.
• Discussion of novel molecular targets and radioligands.
• Exploration of emerging imaging technologies.

Main Results:

• Overexpression of specific peptide hormone receptors on NENs enables targeted radionuclide imaging.
• Established somatostatin receptor imaging is complemented by new radioligands targeting glucagon-like peptide-1 receptors (e.g., exendin-4 for insulinomas).
• Emerging targets include C-X-C motif chemokine receptor-4, fibroblast activation protein, and cholecystokinin-2 receptors, offering new therapeutic avenues for specific NENs like medullary thyroid carcinoma.

Conclusions:

• Molecular imaging represents a significant advancement in the management of NENs.
• Targeted radionuclide imaging is improving the precision of diagnosis and therapy for NENs.
• Continued research into novel molecular targets promises further improvements in NEN patient care.